TP53 mutation is not only the most common genetic event in cancer, but is also associated with more aggressive disease and poorer patient outcomes in many cancers, especially in HNSCC (Poeta et al., 2007; Leroy et al., 2014). The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.